Brain

Anabolic Steroids Alternatives: Muscle Building Supplements from CrazyBulk | Most Selling Muscular Endurance Supplements Bodybuilders Use For Peak Performance & Strength Building in 2025

Discover how CrazyBulk’s Anabolic Steroids Alternatives supplements can enhance muscular endurance, boost strength, and speed up recovery. Learn optimal stacks,…

3 weeks ago

Algernon Closes Second Tranche of Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE…

3 weeks ago

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan

If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the…

3 weeks ago

Yale-Trained Neuroscientist Unveils “Digital Sunshine” Device, Merging Ancient Eastern Wisdom with Modern Brain Science to Revolutionize Sleep

Panbrain Lume Offers a Drug-Free Path to Deeper Sleep and Faster Sleep Onset in Just 8 Minutes, Now Live on…

3 weeks ago

Beyond Air® Announces Transition of Chief Financial Officer

Launched search for permanent successorGARDEN CITY, N.Y., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air”…

3 weeks ago

Neuraxpharm and mjn-neuro announce plans to launch EPISERAS®, a digital health solution using an AI-powered wearable device for the early detection of epileptic seizures

A non-invasive, AI-based, wearable earpiece that continuously monitors brain activity to enable the early detection of seizure risk in real…

3 weeks ago

Subtle Medical Doubles Growth; Showcases New Releases and Strengthened Partnerships at RSNA 2025

Subtle's Latest Solutions Set New Benchmarks for AI-powered Acceleration, Image Quality, and OrganizationMENLO PARK, Calif., Nov. 26, 2025 /PRNewswire/ --…

3 weeks ago

AIRS Medical to Debut AI-Powered Brain Health Quantification and Reporting Solution SwiftSight™-Brain at RSNA 2025

CHICAGO, Nov. 26, 2025 /PRNewswire/ -- AIRS Medical, a leader in AI-powered healthcare solutions, will unveil SwiftSight, a breakthrough brain…

3 weeks ago

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

One Oral Late Breaking Communication and Two Poster PresentationsNEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.…

3 weeks ago

Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096

Key step achieved in advancing HER-096 towards Phase 2 efficacy trial  Espoo, Finland, 26 November 2025: Herantis Pharma Plc (“Herantis”),…

3 weeks ago